Use of mitomycin C and r-tPA for the management of conjunctival membrane and cataracts in a child with conjunctivitis lignosa.
Meire
F M
FM
Claerhout
I
I
Kestelyn
P H
PH
D002648:Child; D003231:Conjunctivitis / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D016685:Mitomycin / Q000627:therapeutic use*; D019384:Nucleic Acid Synthesis Inhibitors / Q000627:therapeutic use*; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*
D005343:Fibrinolytic Agents; D019384:Nucleic Acid Synthesis Inhibitors; D016685:Mitomycin; D010959:Tissue Plasminogen Activator